Mission Therapeutics - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeMission Therapeutics
Mission Therapeutics logo

Mission Therapeutics

0 followers

About Mission Therapeutics

Mission Therapeutics is a biotechnology company focused on the discovery and development of first-in-class therapeutics that inhibit disease-associated deubiquitylating enzymes (DUBs). The company's lead candidates aim to treat serious diseases including Parkinson's Disease, heart and kidney diseases, fibrosis, and rare mitochondria diseases.

Recent News

No recent news for this company.

Recent Deals

Key Team Members

Suhail Nurbhai

Chief Medical Officer

Paul Thompson

Chief Scientific Officer

Anker Lundemose

Chief Executive Officer

Professor Steve Jackson

Founder and Chairman of the Scientific Advisory Board

Key Facts

HQ Location

Cambridge, United Kingdom

Founded

2011

Employees

11 - 50

Status

Private

Website

https://missiontherapeutics.com